newsfilter
← Latest News
GlobeNewswire·

Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

Rezdiffra® (resmetirom) to be featured in more abstracts than any other approved or investigational MASH therapyReal-world evidence abstracts examine Rezdiffra effectiveness, tolerability and treatment persistence in